Life Sciences Tools and Services
Company Overview of Avelas BioSciences, Inc.
Avelas BioSciences, Inc. develops molecularly-targeted in vivo imaging technologies. It offers Avelas Cancer Illuminator, a fluorescent peptide that uses elevated protease activity of invading and metastasizing cancer to fluorescently label cancerous tissue with high sensitivity and specificity; and creates an illuminated cancer map for the surgeon during the operation when used with a fluorescence imaging system. The company also provides Avelas Nerve Illuminator, a fluorescent peptide that selectively illuminates peripheral nerves. Avelas BioSciences, Inc. was incorporated in 2008 and is based in La Jolla, California.
11099 North Torrey Pines Road
La Jolla, CA 92037
Founded in 2008
Key Executives for Avelas BioSciences, Inc.
Chief Executive Officer, President and Director
Co-Founder and Research Collaborator
Vice President of Clinical Affairs
Compensation as of Fiscal Year 2015.
Avelas BioSciences, Inc. Key Developments
Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients
Apr 16 15
Avelas Biosciences announced that it has initiated a Phase 1b study of its lead fluorescent cancer illuminator, AVB-620, in women with primary, non-recurrent breast cancer undergoing surgery. The open label, dose escalation study will enroll up to 39 women with stage I-III breast cancer undergoing lumpectomy or mastectomy and lymph node assessment. The study will evaluate AVB-620 safety and tolerability, pharmacokinetics, and determine the dose needed to generate fluorescence signals in tumor and lymph node tissues to enable recordings and image analysis. Additionally, the study will evaluate the effect of timing of AVB-620 administration, relative to surgery, on fluorescence characteristics.
Avelas BioSciences, Inc. Appoints Steven Chen as Vice President of Clinical Affairs
Apr 16 15
Avelas BioSciences, Inc. has appointed Steven Chen, M.D., as vice president of clinical affairs. Prior to joining Avelas Biosciences, Dr. Chen was an associate professor of surgery and the associate program director of the surgical oncology training program at City of Hope National Medical Center. Before that he served as the chief of breast surgery at UC Davis Medical Center. Dr. Chen maintains a practice in San Diego as director of surgical oncology at OasisMD. Dr. Chen serves as a director on the board of the American Society of Breast Surgeons and the Frederick A. Coller Surgical Society. He also serves on the training committee of the Society of Surgical Oncology which accredits breast surgical oncology training programs, as well as serving on a number of committees for other national professional societies including the American Medical Association and the American College of Surgeons, as well being an active member of the American Society of Clinical Oncology and the Society of University Surgeons.
Avelas BioSciences, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 08:30 AM
Feb 26 15
Avelas BioSciences, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 08:30 AM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|